Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,861.84
(
-0.04%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.05
(
4.82%
)
Bitcoin
75,556.98
(
-0.44%
)
News Focus
News Focus
Post# of 517472
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ato

Send PM Follow Ignore
Followers 0
Posts 14
Boards Moderated 0
Alias Born 03/07/2004

ato

Re: MayoMobile post# 508063

Friday, 11/14/2025 4:05:59 PM

Friday, November 14, 2025 4:05:59 PM

Post# of 517472
wouldn't ABCLEAR 2, ABCLEAR 3, Brain atrophy TIED to ABCLEAR2/3, ADNI comparisons, prodromal comparisons be considered additional data, not new?

Additional data was also provided for Lecanemab, donanemeb and libmeldy as part of their successful re-examinations.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News